OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 1
Data from combined, up to 2021-03-20.
| Vaccinated at 2021-03-20 (%) | Vaccinated at 2021-03-20 (n) | Population | Vaccinated at 2021-03-13 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 66.6% | 201,187 | 302,092 | 66.0% | 0.6% |
| Sex | Female | 66.9% | 128,317 | 191,842 | 66.4% | 0.4% |
| Male | 66.1% | 72,870 | 110,250 | 65.3% | 0.8% | |
| Ethnicity | White - British | 67.2% | 129,087 | 192,220 | 66.6% | 0.6% |
| White - Irish | 68.2% | 1,708 | 2,506 | 67.9% | 0.3% | |
| White - Any other White background | 58.3% | 3,675 | 6,300 | 57.7% | 0.7% | |
| Mixed - White and Black Caribbean | 60.5% | 364 | 602 | 58.1% | 2.3% | |
| Mixed - White and Black African | 50.0% | 126 | 252 | 47.2% | 2.8% | |
| Mixed - White and Asian | 61.8% | 147 | 238 | 58.8% | 2.9% | |
| Mixed - Any other mixed background | 63.2% | 301 | 476 | 60.3% | 2.9% | |
| Asian or Asian British - Indian | 64.0% | 1,330 | 2,079 | 63.0% | 1.0% | |
| Asian or Asian British - Pakistani | 56.3% | 497 | 882 | 54.8% | 1.6% | |
| Asian or Asian British - Bangladeshi | 59.3% | 245 | 413 | 59.3% | 0.0% | |
| Asian or Asian British - Any other Asian background | 58.8% | 700 | 1,190 | 57.6% | 1.2% | |
| Black or Black British - Caribbean | 58.7% | 1,344 | 2,289 | 57.5% | 1.2% | |
| Black or Black British - African | 51.2% | 721 | 1,407 | 49.3% | 2.0% | |
| Black or Black British - Any other Black background | 58.3% | 441 | 756 | 56.5% | 1.9% | |
| Other ethnic groups - Chinese | 58.0% | 203 | 350 | 58.0% | 0.0% | |
| Other ethnic groups - Any other ethnic group | 59.9% | 700 | 1,169 | 59.3% | 0.6% | |
| Patients with any other ethnicity code | 68.0% | 26,537 | 39,004 | 67.5% | 0.6% | |
| Ethnicity not stated | 65.1% | 1,785 | 2,744 | 64.8% | 0.3% | |
| Ethnicity not recorded | 66.2% | 31,171 | 47,089 | 65.8% | 0.4% | |
| Ethnicity (broad categories) | White | 66.9% | 134,491 | 201,040 | 66.3% | 0.6% |
| Mixed | 59.5% | 945 | 1,589 | 57.7% | 1.8% | |
| South Asian | 61.0% | 2,793 | 4,578 | 59.8% | 1.2% | |
| Black | 56.4% | 2,520 | 4,466 | 54.9% | 1.6% | |
| Other | 59.2% | 903 | 1,526 | 58.7% | 0.5% | |
| Unknown | 67.0% | 59,507 | 88,851 | 66.5% | 0.5% | |
| Index of Multiple Deprivation | 1 (most deprived) | 64.4% | 39,256 | 60,921 | 63.8% | 0.7% |
| 2 | 68.7% | 43,358 | 63,070 | 68.0% | 0.8% | |
| 3 | 68.0% | 43,218 | 63,567 | 67.4% | 0.6% | |
| 4 | 66.7% | 40,418 | 60,571 | 66.2% | 0.5% | |
| 5 (least deprived) | 64.9% | 33,796 | 52,087 | 64.5% | 0.4% | |
| Unknown | 60.8% | 1,120 | 1,841 | 60.1% | 0.8% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 67.6% | 176,386 | 260,827 | 67.1% | 0.6% |
| Patients with Immunosuppression | 65.7% | 6,062 | 9,233 | 65.1% | 0.5% | |
| Patients with CKD | 66.5% | 50,225 | 75,523 | 66.2% | 0.3% | |
| Patients who have Chronic Respiratory Disease | 66.1% | 18,480 | 27,965 | 65.7% | 0.4% | |
| Patients with Diabetes | 66.9% | 38,199 | 57,120 | 66.4% | 0.5% | |
| Patients with Chronic Liver disease | 65.9% | 5,215 | 7,917 | 64.9% | 1.0% | |
| Patients with CNS Disease (including Stroke/TIA) | 68.7% | 105,399 | 153,412 | 68.2% | 0.5% | |
| Patients with Chronic heart disease | 66.7% | 72,632 | 108,871 | 66.4% | 0.4% | |
| Patients with Asplenia or Dysfunction of the Spleen | 67.1% | 1,554 | 2,317 | 66.8% | 0.3% | |
| Patients with Wider Learning Disability | 75.2% | 34,118 | 45,395 | 73.9% | 1.3% | |
| Patients with Severe Mental Health | 66.5% | 20,055 | 30,177 | 65.5% | 1.0% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 67.9% | 143,759 | 211,855 | 67.5% | 0.3% |
| Patients with Morbid Obesity | 67.1% | 5,488 | 8,176 | 65.8% | 1.3% | |
| Patients who are pregnant | 23.8% | 35 | 147 | 23.8% | 0.0% |